These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17340023)

  • 21. Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis.
    Sulli A; Soldano S; Pizzorni C; Montagna P; Secchi ME; Villaggio B; Seriolo B; Brizzolara R; Cutolo M
    J Rheumatol; 2009 Jun; 36(6):1235-9. PubMed ID: 19369451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Assessment of microcirculatory system with conventional capillaroscopy in patients with rosacea--preliminary study].
    Kamińiska-Winciorek GM; Brzezińska-Wcisło LA
    Wiad Lek; 2006; 59(9-10):618-22. PubMed ID: 17338116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of microcirculation in oral lichen planus by video-capillaroscopy.
    Scardina GA; Picone V; Cacioppo A; Messina P
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Apr; 103(4):e30-4. PubMed ID: 17241796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgaris.
    Hashizume H; Ito T; Yagi H; Takigawa M; Kageyama H; Furukawa F; Hata M; Shirahama S; Tanaka M; Higashishiba T; Machida H; Tsushima T; Matsushita K
    J Dermatol; 2007 Jul; 34(7):430-4. PubMed ID: 17584318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of nailfold capillaroscopy by x 30 digital epiluminescence (dermoscopy) in patients with Raynaud phenomenon.
    Beltrán E; Toll A; Pros A; Carbonell J; Pujol RM
    Br J Dermatol; 2007 May; 156(5):892-8. PubMed ID: 17388920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of the microcirculation of oral mucosa in healthy subjects.
    Scardina GA; Messina P
    Ital J Anat Embryol; 2003; 108(1):39-48. PubMed ID: 12737514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The correlation between response to oral cyclosporin therapy and systemic inflammation, metabolic abnormality in patients with psoriasis.
    Ohtsuka T
    Arch Dermatol Res; 2008 Nov; 300(10):545-50. PubMed ID: 18797895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psoriatic arthritis treated with cyclosporin A.
    Kokelj F; Lavaroni G; Stinco G
    Allerg Immunol (Paris); 1992 Dec; 24(10):393-4. PubMed ID: 1288546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermittent vs. continuous 1-year cyclosporin use in chronic plaque psoriasis.
    Chaidemenos GC; Mourellou O; Avgoustinaki N; Papakonstantinou M; Karakatsanis G; Katsambas A
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1203-8. PubMed ID: 17894706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Morphological changes in the microcirculatory bed of the skin in patients with psoriasis following treatment].
    Al'banova VI; Mordovtseva VN; Timoshin GG
    Vestn Dermatol Venerol; 1988; (3):4-8. PubMed ID: 3381584
    [No Abstract]   [Full Text] [Related]  

  • 31. [Periungual capillaroscopy in psoriatic arthritis].
    Sallì L; Raimondi F; Pappalardo A
    Clin Ter; 1999; 150(6):409-12. PubMed ID: 10756660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole field laser Doppler imaging of the microcirculation in psoriasis and clinically unaffected skin.
    Hendriks AG; Steenbergen W; Hondebrink E; van Hespen JC; van de Kerkhof PC; Seyger MM
    J Dermatolog Treat; 2014 Feb; 25(1):18-21. PubMed ID: 23441953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term treatment with cyclosporin in severe psoriasis: four years of experience.
    Garcovich A; Gatti M; Pompili A; Olivetti G; Catamo F
    Acta Derm Venereol Suppl (Stockh); 1994; 186():92-3. PubMed ID: 8073852
    [No Abstract]   [Full Text] [Related]  

  • 35. Two cases of chronic lymphoproliferative disorders in psoriatic patients treated with cyclosporine: hairy cell leukemia and Waldenstrom macroglobulinemia.
    Fozza C; Dore F; Bonfigli S; Podda L; Longinotti M
    Eur J Dermatol; 2005; 15(4):271-3. PubMed ID: 16048757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of psoriatic nails with low-dose cyclosporine administration.
    Syuto T; Abe M; Ishibuchi H; Ishikawa O
    Eur J Dermatol; 2007; 17(3):248-9. PubMed ID: 17478392
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of HESA-A on psoriasis vulgaris.
    Ahmadi A; Barikbin B; Naseri M; Mohagheghi M
    J Drugs Dermatol; 2008 Jun; 7(6):559-61. PubMed ID: 18561587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statistical evaluation and experimental design of a psoriasis xenograft transplantation model treated with cyclosporin A.
    Stenderup K; Rosada C; Alifrangis L; Andersen S; Dam TN
    Exp Dermatol; 2011 May; 20(5):441-4. PubMed ID: 21426413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased insulin-like growth factor binding protein-3 expression level in psoriatic tissue before and after systemic treatment with cyclosporine A and methotrexate.
    Ozden MG; Ilter N; Suer OE; Solaktekin N; Gürer MA
    Int J Dermatol; 2008 Nov; 47(11):1177-83. PubMed ID: 18986456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exacerbation of paranoid schizophrenia in a psoriatic patient after treatment with cyclosporine A, but not with etanercept.
    Di Nuzzo S; Zanni M; De Panfilis G
    J Drugs Dermatol; 2007 Oct; 6(10):1046-7. PubMed ID: 17966184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.